Dabur vs Marico (2026): Rural Growth, Premiumisation, Margins & Which Is Better?

Dabur vs Marico financial comparison

Dabur's Q1 FY2027 was stronger than its share price suggests

Dabur reported consolidated revenue growth of 10.6% and net profit growth of 15% in Q1 FY2027.

Revenue reached approximately ₹3,764 crore.

Net profit increased to about ₹591 crore.

Operating profit increased 11%.

India FMCG revenue increased approximately 9.5%, while underlying volume growth was around 5%.

This is not a distressed operating result.

Yet Dabur's stock is down almost 24% over one year in Bull Run's current snapshot.

The disconnect partly reflects concerns about long-term growth, valuation and whether Dabur can consistently accelerate beyond mid-single-digit volume expansion.

Rural India is still one of Dabur's most important advantages

Dabur reported rural consumption growth of 6.2% in Q1 FY2027, compared with 4.6% in urban markets.

Rural demand therefore grew roughly 170 basis points faster.

Dabur's portfolio is unusually well suited to rural and semi-urban consumption because it spans oral care, hair oils, healthcare, digestive products, honey, juices and affordable daily-use products.

The company says its products reach eight out of ten Indian households.

When rural incomes improve, Dabur can benefit from both higher penetration and trade-up toward branded products.

Dabur's premium brands are growing faster than the base portfolio

Dabur said its premium brands grew at roughly twice the rate of regular brands in Q1.

New products contributed approximately 2.6% of revenue.

This matters because Dabur has historically been associated with mass-market Ayurveda and household products.

Premiumisation creates an opportunity to improve realisations and margins without abandoning the distribution moat built around mass-market categories.

The challenge is maintaining credibility while expanding beyond the products consumers traditionally associate with the Dabur brand.

Dabur's growth was broad rather than dependent on one category

Home and Personal Care grew approximately 12.3%, Food and Beverages 7.2%, and Healthcare 5.5% in Q1 FY2027.

Hair oils grew about 17.6%.

Shampoo grew 23%.

Oral care increased 9%.

Digestives grew approximately 11.2%.

Foods increased almost 29.2%.

Premium beverage categories such as Real Activ and coconut water grew much faster than the overall beverages portfolio.

This breadth reduces dependence on one franchise, although it can make category execution more complex.

Dabur's international business is becoming more important

International revenue grew approximately 15.5% in rupee terms in Q1 FY2027.

Bangladesh grew around 34.3%.

Egypt increased approximately 28.4%.

Sub-Saharan Africa grew around 28%.

Turkey increased approximately 26.9%.

The UK grew around 21.9%.

That geographic diversification is useful, although Middle East exposure creates currency, geopolitical and supply-chain risks.

Marico's growth model is increasingly about becoming less dependent on Parachute

Marico still owns one of India's strongest household franchises in Parachute, but management is deliberately broadening the portfolio.

Foods, premium personal care and digital-first brands have become central to the next phase of growth.

At the end of FY2026, foods and premium personal care represented roughly 23% of India revenue.

Management expects that contribution to rise further in FY2027 and toward roughly one-third of India revenue by FY2030.

This transformation is one reason investors value Marico more highly than a traditional hair-oil business.

Marico's current Q1 momentum is significantly stronger

Bull Run's June 2026 financial snapshot shows Marico quarterly sales growth of approximately 21.4% and quarterly profit growth of 25%.

That is materially above Dabur's 10.6% sales growth and approximately 15% profit growth.

Marico entered FY2027 after a strong FY2026 exit, when Q4 consolidated revenue increased more than 22% and PAT grew roughly 18%.

Management has guided toward double-digit consolidated revenue growth in FY2027 and high-teen EBITDA growth, subject to commodity and geopolitical conditions.

The market is therefore pricing Marico as a company capable of sustaining faster growth.

Marico's return ratios are exceptional for a consumer company

Marico's ROE of approximately 43.1% and ROCE of 39.3% are dramatically above Dabur's 17.1% and 21.3%.

The gap reflects Marico's asset-light brand economics and efficient capital base.

A company producing more than 40% ROE does not need enormous retained capital to compound earnings.

That supports higher valuation multiples.

The problem for a new investor is that Marico's valuation already assumes much of this quality continues.

Dabur is cheaper, but its long-term growth record explains part of the discount

Dabur's five-year sales growth is approximately 6.65% and profit growth only around 2.28% in Bull Run's current series.

Marico has compounded sales at approximately 11.08% and profit around 8.50%.

EPS growth shows the same pattern.

Dabur therefore needs sustained acceleration for its lower P/E to become a genuine growth-adjusted bargain.

A cheaper stock is not automatically inexpensive if earnings compound slowly.

Dabur's cash conversion is better than its growth record

Dabur converts reported profit into operating cash very effectively.

Operating cash flow is approximately 1.36 times net profit.

Marico's comparable figure is about 1.18x.

Dabur also has the slightly larger five-year free-cash-flow figure in Bull Run's current dataset, approximately ₹7,433 crore versus Marico at ₹6,322 crore.

This is an important counterweight to Dabur's weaker historical earnings growth.

The business remains highly cash generative.

Balance-sheet risk is low at both companies

Dabur and Marico both have debt-to-equity below 0.10 in Bull Run's current data.

Dabur's ratio is approximately 0.09.

Marico's is around 0.08.

Interest coverage is higher at Marico, around 44x versus Dabur at 17.7x.

Dabur has the higher current ratio, approximately 1.70x versus Marico at 1.43x.

Neither company faces a conventional leverage concern.

Dabur is the better current dividend-income stock

Dabur currently yields approximately 1.91%, compared with Marico at just 0.47%.

This is not an ITC-like income story, but the difference is material.

Marico's lower yield reflects both its high market valuation and its preference to reinvest into growth businesses and acquisitions.

For a shareholder focused on present income rather than reinvestment, Dabur has the advantage.

Marico's international portfolio is more concentrated, but management is diversifying it

About 24% of Marico's FY2026 revenue came from overseas markets.

Bangladesh historically represented a large portion of the international business.

Management is deliberately reducing that concentration by growing Vietnam, MENA, South Africa and other markets.

It also wants premium categories to form a larger share of international revenue.

This can improve resilience but requires strong execution across very different consumer markets.

Digital-first brands are Marico's highest-upside experiment

Marico's newer brands give the company a path into categories far removed from coconut oil.

Its digital-first portfolio has included brands across wellness, grooming and premium personal care.

Management reported an exit annualised revenue run rate above ₹1,100 crore for the digital-first portfolio in FY2026.

The company expects those brands to move toward double-digit EBITDA margins.

If they do, Marico can prove that digital acquisitions are not merely revenue growth but profitable portfolio expansion.

Dabur's equivalent opportunity is premiumisation inside trusted categories

Dabur does not need to reinvent itself as completely as Marico because several of its legacy categories align naturally with health and wellness trends.

Honey, digestive products, health juices, oral care and Ayurvedic healthcare already fit consumer interest in wellness.

The opportunity is to modernise packaging, distribution, formats and premium tiers without weakening brand trust.

This route may produce slower growth than digital acquisitions but potentially carries lower brand-extension risk.

The stocks have moved in opposite directions

Dabur is trading almost at its recorded 52-week low and its RSI is around 20.

That is extreme technical weakness.

It does not automatically mean the stock is undervalued because its P/E remains close to 39x.

Marico remains much closer to its 52-week high, reflecting stronger earnings expectations.

Dabur: what the recovery case rests on

Marico: what investors are paying 58x earnings for

Dabur vs Marico FAQs

Which stock is cheaper?

Dabur. It trades at approximately 38.8x earnings versus Marico at about 58.1x.

Which has higher ROE?

Marico, at approximately 43.1% versus Dabur at around 17.1%.

Which has higher ROCE?

Marico, at approximately 39.3% versus Dabur at about 21.3%.

Which has better current sales growth?

Marico in Bull Run's current Q1 FY2027 data, at approximately 21.4% versus Dabur at 10.6%.

Which has better current profit growth?

Marico, at approximately 25% versus Dabur around 15%.

Which is stronger in rural India?

Dabur has particularly deep rural exposure and reported rural consumption growing faster than urban consumption in Q1 FY2027.

Which has a better dividend yield?

Dabur, at approximately 1.91% versus Marico at around 0.47%.

Why does Marico trade at a higher valuation?

Marico currently has much higher ROE and ROCE, faster growth and stronger recent share-price momentum, while investors are also assigning value to foods, premium personal care and digital-first brands.

Research sources

• Bull Run current fundamental, ownership and technical data
• Bull Run Smart Screeners
• Dabur Q1 FY2027 financial results
• Dabur Q1 FY2027 official press release
• Dabur investor relations
• Marico official website and Q1 FY2027 investor updates
• Marico FY2026 exit performance and FY2027 outlook
• Marico business and international revenue profile